All News #Library
Biotech
Vivet Presents Gene Therapy Data for Cerebrotendinous Xanthomatosis
14 Nov 2024 //
GLOBENEWSWIRE
Vivet Presents Posters On Cerebrotendinous Xanthomatosis At ESGCT
22 Oct 2024 //
GLOBENEWSWIRE
Vivet receives EUR 4.9 million to advance development of a gene therapy
01 Feb 2024 //
PR NEWSWIRE

Market Place
Sourcing Support